Percutaneous transhepatic Cholangiography (PTC) is a treatment technique that allows you to examine the anatomy of your biliary tract. This is a radiologic procedure in which a contrast medium is injected into the bile duct before an X-ray is performed. Percutaneous transhepatic Cholangiography (PTC), involves the transhepatic inserting of a needle in a bile conduit and then injecting contrast material to opacify bile drains. PTC is usually performed for the evaluation of patients who are found to have biliary duct dilation on ultrasonography or other imaging tests and who are not candidates for endoscopic retrograde cholangiopancreatography (ERCP). This group includes patients with a surgically altered anatomy that prevents endoscopic access to their biliary tree.
PTC is more sensitive and specific than CT scan and ultrasonography in identifying the source and location of obstructions to the biliary system. The rapid rise in rise in awareness regarding endoscopic retrograde cholangiopancreatography devices is amongst the important factor expected to intensify the growth and demand for endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) devices market. The global market is expected to grow over the 2021-2028 period due to an increase in benign tumors of the liver and pancreas worldwide. Awareness programs and the rise of awareness are also contributing factors. The rise in government initiatives and rapid increase in awareness about endoscopic retrograde cholangiopancreatography devices and their availability is also likely to enhance the growth of the market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Percutaneous Transhepatic Cholangiography Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Percutaneous Transhepatic Cholangiography Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.